Skip to main content

ADAPTACIONES METABOLICAS DE LAS NEURONAS Y LA GLIA A LOS ROS ENDOGENOS MITOCONDRIALES: IMPLICACIONES TERAPEUTICAS PARA LA NEURODEGENERACION

SAF2013-41177-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Uncertainties in pentose-phosphate pathway flux assessment underestimate its contribution to neuronal glucose consumption: relevance for neurodegeneration and aging

  • Bouzier-Sore, Anne-Karine
  • Bolaños, Juan P.
The pentose-phosphate pathway (PPP) promotes the oxidative decarboxylation of glucose-6-phosphate (G6P) in two consecutive steps, catalyzed by glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD), yielding ribulose-5-phosphate (Ru5P) (Figure 1) (Wamelink et al., 2008)., This study has received financial support from the French State in the frame of the “Investments for the future” Programme IdEx and Labex (TRAIL) Bordeaux, reference ANR-10-IDEX-03-02 and ANR-10-LABX-57. JB is funded by MINECO (SAF2013-41177-R), ISCIII (RD12/0043/0021), EU-ITN (608381), NIH/NIDA (1R21DA037678-01), MECD (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D+i, PRX14/00387), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating pink1

  • Requejo-Aguilar, Raquel
  • López-Fabuel, Irene
  • Jimenez-Blasco, Daniel
  • Fernández, Emilio
  • Almeida, Angeles
  • Bolaños, Juan P.
PMCID: PMC4385472, Using mouse embryonic fibroblasts (MEFs) from DJ1-knockout mice, in the present study, we show that DJ1, by binding with Foxo3a (forkhead box O3a), transcriptionally activates pink1 (phosphatase and tensin homologue deleted on chromosome 10-induced protein kinase-1) gene. Moreover, we demonstrate that, by promoting pink1 expression, DJ1 represses the rate of glycolysis and cell proliferation., This work was funded by the Spanish Ministerio de Economia y Competitividad [SAF2013-41177-R], the Instituto de Salud Carlos III [RD12/0043/0021], the SP3-People-MC-ITN programme of the European Commission [608381], the National Institutes of Drug Abuse/National Institutes of Health (NIH/NIDA) [1R21DA03767801], and the European Regional Development Fund to JPB. AAP was funded by the Instituto de Salud Carlos III [PI12/00685; RD12/0014/0007]. ILB is the recipient of a FPI Fellowship from the Spanish Ministerio de Economia y Competitividad (Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons

  • Veas-Pérez de Tudela, Miguel
  • Maestre, Carolina
  • Delgado-Esteban, María
  • Bolaños, Juan P.
  • Almeida, Angeles
The anaphase-promoting complex/cyclosome (APC/C) is an E3 ubiquitin ligase that regulates cell cycle progression in proliferating cells. To enter the S-phase, APC/C must be inactivated by phosphorylation of its cofactor, Cdh1. In post-mitotic cells such as neurons APC/C-Cdh1 complex is highly active and responsible for the continuous degradation of mitotic cyclins. However, the specific molecular pathway that determines neuronal cell cycle blockade in post-mitotic neurons is unknown. Here, we show that activation of glutamatergic receptors in rat cortical primary neurons endogenously triggers cyclin-dependent kinase-5 (Cdk5)-mediated phosphorylation of Cdh1 leading to its cytoplasmic accumulation and disassembly from the APC3 core protein, causing APC/C inactivation. Conversely, pharmacological or genetic inhibition of Cdk5 promotes Cdh1 ubiquitination and proteasomal degradation. Furthermore, we show that Cdk5-mediated phosphorylation and inactivation of Cdh1 leads to p27 depletion, which switches on the cyclin D1-cyclin-dependent kinase-4 (Cdk4)-retinoblastoma protein (pRb) pathway to allow the S-phase entry of neurons. However, neurons do not proceed through the cell cycle and die by apoptosis. These results indicate that APC/C-Cdh1 actively suppresses an aberrant cell cycle entry and death of neurons, highlighting its critical function in neuroprotection., This work was funded by The Instituto de Salud Carlos III Grants PI12/00685 and RD12/0014/0007 (A.A.P.), RD12/0043/0021 (J.P.B.), FI10/00492 (M.V.-P.d.T.), and CP14/00010 (M.D.-E.), Ministerio de Economia y Competitividad Grant SAF2013-41177-R (J.P.B.), The E.U. SP3-People-MC-ITN programme (608381; J.P.B.), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Astrocyte NMDA receptors' activity sustains neuronal survival through a Cdk5-Nrf2 pathway

  • Jimenez-Blasco, Daniel
  • Santofimia-Castaño, Patricia
  • Gonzalez, Antonio
  • Almeida, Angeles
  • Bolaños, Juan P.
Neurotransmission unavoidably increases mitochondrial reactive oxygen species. However, the intrinsic antioxidant defense of neurons is weak and hence the mechanism whereby these cells are physiologically protected against oxidative damage is unknown. Here we found that the antioxidant defense of neurons is repressed owing to the continuous protein destabilization of the master antioxidant transcriptional activator, nuclear factor-erythroid 2-related factor-2 (Nrf2). By contrast, Nrf2 is highly stable in neighbor astrocytes explaining their robust antioxidant defense and resistance against oxidative stress. We also show that subtle and persistent stimulation of N-methyl-d-aspartate receptors (NMDAR) in astrocytes, through a mechanism not requiring extracellular Ca 2+ influx, upregulates a signal transduction pathway involving phospholipase C-mediated endoplasmic reticulum release of Ca 2+ and protein kinase Cδ activation. Active protein kinase Cδ promotes, by phosphorylation, the stabilization of p35, a cyclin-dependent kinase-5 (Cdk5) cofactor. Active p35/Cdk5 complex in the cytosol phosphorylates Nrf2 at Thr395, Ser433 and Thr439 that is sufficient to promote Nrf2 translocation to the nucleus and induce the expression of antioxidant genes. Furthermore, this Cdk5-Nrf2 transduction pathway boosts glutathione metabolism in astrocytes efficiently protecting closely spaced neurons against oxidative damage. Thus, intercellular communication through NMDAR couples neurotransmission with neuronal survival., DJ-B is the recipient of a FIS Fellowship. PS-C was granted a fellowship from Gobierno de Extremadura (PD10058; Consejería de Empleo, Empresa e Innovación) and European Social Fund. This work was funded by the Spanish Ministerio de Economia y Competitividad (to JPB, grant number SAF2013-41177-R), the Instituto de Salud Carlos III (to JPB, grant number RD12/0043/0021; to AA, grant numbers PI12/00685 and RD12/0014/0007), Junta de Castilla y Leon (to JPB, SA003U13), the SP3-People-MC-ITN program of the European Commission (to JPB, 608381 TINTIN), the National Institutes of Drug Abuse/National Institutes of Health (NIH/NIDA) (to JPB, 1R21DA037678-01) and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Melatonin induces the expression of Nrf2-regulated antioxidant enzymes via PKC and Ca2+ influx activation in mouse pancreatic acinar cells

  • Santofimia-Castaño, Patricia
  • Clea Ruy, Deborah
  • Garcia-Sanchez, Lourdes
  • Jimenez-Blasco, Daniel
  • Fernandez-Bermejo, Miguel
  • Bolaños, Juan P.
  • Salido, Gines M.
  • Gonzalez, Antonio
The goal of this study was to evaluate the potential activation of the nuclear factor erythroid 2-related factor and the antioxidant-responsive element (Nrf2–ARE) signaling pathway in response to melatonin in isolated mouse pancreatic acinar cells. Changes in intracellular free Ca2+ concentration were followed by fluorimetric analysis of fura-2-loaded cells. The activations of PKC and JNK were measured by Western blot analysis. Quantitative reverse transcription–polymerase chain reaction was employed to detect the expression of Nrf2-regulated antioxidant enzymes. Immunocytochemistry was employed to determine nuclear location of phosphorylated Nrf2, and the cellular redox state was monitored following MitoSOX Red-derived fluorescence. Our results show that stimulation of fura-2-loaded cells with melatonin (1 µM to 1 mM), in the presence of Ca2+ in the extracellular medium, induced a slow and progressive increase of [Ca2+]c toward a stable level. Melatonin did not inhibit the typical Ca2+ response induced by CCK-8 (1 nM). When the cells were challenged with indoleamine in the absence of Ca2+ in the extracellular solution (medium containing 0.5 mM EGTA) or in the presence of 1 mM LaCl3, to inhibit Ca2+ entry, we could not detect any change in [Ca2+]c. Nevertheless, CCK-8 (1 nM) was able to induce the typical mobilization of Ca2+. When the cells were incubated with the PKC activator PMA (1 µM) in the presence of Ca2+ in the extracellular medium, we observed a response similar to that noted when the cells were challenged with melatonin 100 µM. However, in the presence of Ro31-8220 (3 µM), a PKC inhibitor, stimulation of cells with melatonin failed to evoke changes in [Ca2+]c. Immunoblots, using an antibody specific for phospho-PKC, revealed that melatonin induces PKCα activation, either in the presence or in the absence of external Ca2+. Melatonin induced the phosphorylation and nuclear translocation of the transcription factor Nrf2, and evoked a concentration-dependent increase in the expression of the antioxidant enzymes NAD(P)H-quinone oxidoreductase 1, catalytic subunit of glutamate-cysteine ligase, and heme oxygenase-1. Incubation of MitoSOX Red-loaded pancreatic acinar cells in the presence of 1 nM CCK-8 induced a statistically significant increase in dye-derived fluorescence, reflecting an increase in oxidation, that was abolished by pretreatment of cells with melatonin (100 µM) or PMA (1 µM). On the contrary, pretreatment with Ro31-8220 (3 µM) blocked the effect of melatonin on CCK-8-induced increase in oxidation. Finally, phosphorylation of JNK in the presence of CCK-8 or melatonin was also observed. We conclude that melatonin, via modulation of PKC and Ca2+ signaling, could potentially stimulate the Nrf2-mediated antioxidant response in mouse pancreatic acinar cells., This work was supported by Junta de Extremadura-FEDER. Patricia Santofimia-Castaño was granted a fellowship from Fundacion Tatiana Perez de Guzman el Bueno. J.P.B. is funded by the Spanish Ministerio de Economia y Competitividad (SAF2013-41177-R), the Instituto de Salud Carlos III (RD12/0043/0021), the SP3-People-MC-ITN programme of the European Commission (608381), the National Institute on Drug Abuse (National Institutes of Health; 1R21DA037678-01), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of Bcl-xL–ATP synthase interaction by mitochondrial cyclin B1–cyclin-dependent kinase-1 determines neuronal survival

  • Veas-Pérez de Tudela, Miguel
  • Delgado-Esteban, María
  • Maestre, Carolina
  • Bobo-Jimenez, Veronica
  • Jimenez-Blasco, Daniel
  • Vecino, Rebeca
  • Bolaños, Juan P.
  • Almeida, Angeles
The survival of postmitotic neurons needs continuous degradation of cyclin B1, a mitotic protein accumulated aberrantly in the damaged brain areas of Alzheimer's disease and stroked patients. Degradation of cyclin B1 takes place in the proteasome after ubiquitylation by the anaphase-promoting complex/cyclosome (APC/C)–cadherin 1 (Cdh1), an E3 ubiquitin ligase that is highly active in neurons. However, during excitotoxic damage—a hallmark of neurological disorders—APC/C–Cdh1 is inactivated, causing cyclin B1 stabilization and neuronal death through an unknown mechanism. Here, we show that an excitotoxic stimulus in rat cortical neurons in primary culture promotes cyclin B1 accumulation in the mitochondria, in which it binds to, and activates, cyclin-dependent kinase-1 (Cdk1). The cyclin B1–Cdk1 complex in the mitochondria phosphorylates the anti-apoptotic protein B-cell lymphoma extra-large (Bcl-xL), leading to its dissociation from the β subunit of F1Fo–ATP synthase. The subsequent inhibition of ATP synthase activity causes complex I oxidative damage, mitochondrial inner membrane depolarization, and apoptotic neuronal death. These results unveil a previously unrecognized role for mitochondrial cyclin B1 in the oxidative damage associated with neurological disorders., This work was funded by Instituto de Salud Carlos III Grants PI12/00685 and RD12/0014/0007 (A.A.P.), RD12/0043/0021 (J.P.B.), FI10/00492 (M.V.-P.d.T.), and CP14/00010 (M.D.-E.), Ministerio de Economia y Competitividad Grant SAF2013-41177-R (J.P.B.), SP3-People-MC-ITN programme of the European Commission Grant 608381 (J.P.B.), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bioenergetics and redox adaptations of astrocytes to neuronal activity

  • Bolaños, Juan P.
Neuronal activity is a high-energy demanding process recruiting all neural cells that adapt their metabolism to sustain the energy and redox balance of neurons. During neurotransmission, synaptic cleft glutamate activates its receptors in neurons and in astrocytes, before being taken up by astrocytes through energy costly transporters. In astrocytes, the energy requirement for glutamate influx is likely to be met by glycolysis. To enable this, astrocytes are constitutively glycolytic, robustly expressing 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), an enzyme that is negligibly present in neurons by continuous degradation because of the ubiquitin-proteasome pathway via anaphase-promoting complex/cyclosome (APC)-Cdh1. Additional factors contributing to the glycolytic frame of astrocytes may include 5′-AMP-activated protein kinase (AMPK), hypoxia-inducible factor-1 (HIF-1), pyruvate kinase muscle isoform-2 (PKM2), pyruvate dehydrogenase kinase-4 (PDK4), lactate dehydrogenase-B, or monocarboxylate transporter-4 (MCT4). Neurotransmission-associated messengers, such as nitric oxide or ammonium, stimulate lactate release from astrocytes. Astrocyte-derived glycolytic lactate thus sustains the energy needs of neurons, which in contrast to astrocytes mainly rely on oxidative phosphorylation. Neuronal activity unavoidably triggers reactive oxygen species, but the antioxidant defense of neurons is weak; hence, they use glucose for oxidation through the pentose-phosphate pathway to preserve the redox status. Furthermore, neural activity is coupled with erythroid-derived erythroid-derived 2-like 2 (Nrf2) mediated transcriptional activation of antioxidant genes in astrocytes, which boost the de novo glutathione biosynthesis in neighbor neurons. Thus, the bioenergetics and redox programs of astrocytes are adapted to sustain neuronal activity and survival. Developing therapeutic strategies to interfere with these pathways may be useful to combat neurological diseases., J.P.B. is funded by the MINECO (SAF2013‐41177‐R; RTC‐2015‐3237‐1), the Instituto de Salud Carlos III (RD12/0043/0021), the E.U. SP3‐People‐MC‐ITN programme (608381), the E.U. BATCure grant (666918), the European Regional Development Fund, and the NIH/NIDA (1R21DA037678‐01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes

  • López-Fabuel, Irene
  • Le Douce, Juliette
  • Logan, Angela
  • James, Andrew M.
  • Bonvento, Gilles
  • Murphy, Michael P.
  • Almeida, Angeles
  • Bolaños, Juan P.
Neurons depend on oxidative phosphorylation for survival, whereas astrocytes do not. Mitochondrial respiratory chain (MRC) complexes can be organized in higher structures called supercomplexes, which dictate MRC electron flux and energy efficiency. Whether the specific metabolic shapes of neurons and astrocytes are determined by the specific organization of MRC complexes is unknown. Here, we found that, in astrocytes, most complex I is free, resulting in poor mitochondrial respiration but high reactive oxygen species (ROS) production. In contrast, neurons show complex I to be mostly embedded into supercomplexes, thus resulting in high mitochondrial respiration and low ROS production. Thus, MRC organization dictates different bioenergetics preferences of neurons and astrocytes impacting on ROS production, possibly playing a role in neurodegenerative diseases., J.P.B. is funded by the Ministry of Economy and Competitiveness (SAF2013-41177-R), Instituto de Salud Carlos III (RD12/0043/0021), European Union (EU) SP3-People-MC-ITN Programme (608381), EU BATCure Grant 666918, and NIH/National Institute on Drug Abuse Grant 1R21DA037678-01. A.A. is funded by Instituto de Salud Carlos III (PI12/00685 and RD12/0014/0007)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

α-Ketoglutarate dehydrogenase complex moonlighting: ROS signalling added to the list

  • Fernández, Emilio
  • Bolaños, Juan P.
An Editorial highlight for ‘Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?’, J.P.B. is funded by the MINECO (SAF2013-41177-R), the Instituto de Salud Carlos III (RD12/0043/0021), the E.U. SP3-People-MC-ITN programme (608381), the EU BATCure grant (666918), andthe NIH/NIDA (1R21DA037678-01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondrial control of cell bioenergetics in Parkinson's disease

  • Requejo-Aguilar, Raquel
  • Bolaños, Juan P.
PMCID: PMC5065935, Parkinson disease (PD) is a neurodegenerative disorder characterized by a selective loss of dopaminergic neurons in the substantia nigra. The earliest biochemical signs of the disease involve failure in mitochondrial-endoplasmic reticulum cross talk and lysosomal function, mitochondrial electron chain impairment, mitochondrial dynamics alterations, and calcium and iron homeostasis abnormalities. These changes are associated with increased mitochondrial reactive oxygen species (mROS) and energy deficiency. Recently, it has been reported that, as an attempt to compensate for the mitochondrial dysfunction, neurons invoke glycolysis as a low-efficient mode of energy production in models of PD. Here, we review how mitochondria orchestrate the maintenance of cellular energetic status in PD, with special focus on the switch from oxidative phosphorylation to glycolysis, as well as the implication of endoplasmic reticulum and lysosomes in the control of bioenergetics., J.P.B. is funded by the MINECO (SAF2013-41177-R; RTC-2015-3237-1), the ISCIII (RD12/0043/0021), the EU SP3-People-MC-ITN program (608381), the EU BATCure grant (666918), the NIH/NIDA (1R21DA037678-01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

NRF2 orchestrates the metabolic shift during induced pluripotent stem cell reprogramming

  • Hawkins, Kate E.
  • Fernández, Emilio
  • Bolaños, Juan P.
  • Duchen, Michael R.
  • McKay, Tristan R.
This is an open access article under the CC BY license.-- et al., The potential of induced pluripotent stem cells (iPSCs) in disease modeling and regenerative medicine is vast, but current methodologies remain inefficient. Understanding the cellular mechanisms underlying iPSC reprogramming, such as the metabolic shift from oxidative to glycolytic energy production, is key to improving its efficiency. We have developed a lentiviral reporter system to assay longitudinal changes in cell signaling and transcription factor activity in living cells throughout iPSC reprogramming of human dermal fibroblasts. We reveal early NF-κB, AP-1, and NRF2 transcription factor activation prior to a temporal peak in hypoxia inducible factor α (HIFα) activity. Mechanistically, we show that an early burst in oxidative phosphorylation and elevated reactive oxygen species generation mediates increased NRF2 activity, which in turn initiates the HIFα-mediated glycolytic shift and may modulate glucose redistribution to the pentose phosphate pathway. Critically, inhibition of NRF2 by KEAP1 overexpression compromises metabolic reprogramming and results in reduced efficiency of iPSC colony formation., K.E.H. and S.J. were partly funded by St George’s University of London Enterprize Fund. J.M.K.M.D. and S.N.W. are funded by ERC grant Somabio (260862). T.R.M. and S.N.W. are funded by the NC3Rs (NC/L001780/1). J.P.B. is funded by MINECO (SAF2013-41177-R), ISCIII (RD12/0043/0021), EU-SP3-People-MC-ITN (608381), and NIH/NIDA (1R21DA037678-01). V.N.K. is funded by Action Medical Research and The Henry Smith Charity (GN2158), and P.J.K. is funded by Barts and the London Charity (417/2088). T.R.M. and J.B. were each funded by EU Horizon2020; BATCure 666918., Open access funded by European Research Council., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism

  • Rodríguez González, Cristina
  • Sobrino, Tomás
  • Agulla, Jesús
  • Bobo-Jimenez, Veronica
  • Ramos-Araque, María E.
  • Duarte, Juan J.
  • Gómez Sánchez, José Carlos
  • Bolaños, Juan P.
  • Castillo, José
  • Almeida, Angeles
Intracerebral hemorrhage (ICH) is a devastating subtype of stroke that lacks effective therapy and reliable prognosis. Neovascularization following ICH is an essential compensatory response that mediates brain repair and modulates the clinical outcome of stroke patients. However, the mechanism that dictates this process is unknown. Bone marrow-derived endothelial progenitor cells (EPCs) promote endothelial repair and contribute to ischemia-induced neovascularization. The human Tp53 gene harbors a common single-nucleotide polymorphism (SNP) at codon 72, which yields an arginine-to-proline amino-acidic substitution (Arg72Pro) that modulates the apoptotic activity of the p53 protein. Previously, we found that this SNP controls neuronal susceptibility to ischemia-induced apoptosis in vitro. Here, we evaluated the impact of the Tp53 Arg72Pro SNP on vascular repair and functional recovery after ICH. We first analyzed EPC mobilization and functional outcome based on the modified Rankin scale scores in a hospital-based cohort of 78 patients with non-traumatic ICH. Patients harboring the Pro allele of the Tp53 Arg72Pro SNP showed higher levels of circulating EPC-containing CD34 + cells, EPC-mobilizing cytokines-vascular endothelial growth factor and stromal cell-derived factor-1α-and good functional outcome following ICH, when compared with the homozygous Arg allele patients, which is compatible with increased neovascularization. To assess directly whether Tp53 Arg72Pro SNP regulated neovascularization after ICH, we used the humanized Tp53 Arg72Pro knock-in mice, which were subjected to the collagenase-induced ICH. The brain endothelial cells of the Pro allele-carrying mice were highly resistant to ICH-mediated apoptosis, which facilitated cytokine-mediated EPC mobilization, cerebrovascular repair and functional recovery. However, these processes were not observed in the Arg allele-carrying mice. These results reveal that the Tp53 Arg72Pro SNP determines neovascularization, brain repair and neurological recovery after ICH. This study is the first in which the Pro allele of Tp53 is linked to vascular repair and ability to functionally recover from stroke., This work was funded by The Instituto de Salud Carlos III Grants PI12/00685, PI15/00473 and RD12/0014/0007 (to AA), RD12/0014/0001 (to JC), PI14/01879 and CP12/03121 (to TS), RD12/0043/0021 (to JPB), CD11/00348 (to CR), CD12/00685 (to JA), CM11/00140 (to JJD), CM14/00096 (to MER-A), The Ministerio de Economía y Competitividad Grant SAF2013-41177-R (JPB), The Junta de Castilla y León (GRS843/A/13 and GRS1004/A/14; to JCG-S), The Xunta de Galicia (GRC2014/027; to JC) and the European Regional Development Fund (ERDF)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of BDNF release by ARMS/Kidins220 through modulation of synaptotagmin-IV levels

  • López-Benito, Saray
  • Sánchez-Sánchez, Julia
  • Brito, Verónica
  • Calvo, Laura
  • Lisa, Silvia
  • Torres-Valle, María
  • Palko,Mary E.
  • Vicente García, Cristina
  • Fernandez-Fernandez, Seila
  • Bolaños, Juan P.
  • Ginés, Silvia
  • Tessarollo, Lino
  • Arévalo, Juan Carlos
BDNF is a growth factor with important roles in the nervous system in both physiological and pathological conditions, but the mechanisms controlling its secretion are not completely understood. Here, we show that ARMS/Kidins220 negatively regulates BDNF secretion in neurons from the CNS and PNS. Downregulation of the ARMS/Kidins220 protein in the adult mouse brain increases regulated BDNF secretion, leading to its accumulation in the striatum. Interestingly, two mouse models of Huntington's disease (HD) showed increased levels of ARMS/Kidins220 in the hippocampus and regulated BDNF secretion deficits. Importantly, reduction of ARMS/Kidins220 in hippocampal slices from HD mice reversed the impaired regulated BDNF release. Moreover, there are increased levels of ARMS/Kidins220 in the hippocampus and PFC of patients with HD. ARMS/Kidins220 regulates Synaptotagmin-IV levels, which has been previously observed to modulate BDNF secretion. These data indicate that ARMS/Kidins220 controls the regulated secretion of BDNF and might play a crucial role in the pathogenesis of HD., This work was supported by MINECO BFU2011-22898, BFU2014-51846-R, and BFU2017-82667-R to J.C.A. and SAF2013-41177-RtoJ.P.B., andthe EU 7th Framework Program(Marie Curie IRG and PAINCAGE)toJ.C.A. S.L.-B.was supported by Consejería de Educacio´n Junta de Castilla y Leo´n and the European Social Fund. M.E.P. and L.T. were supported by the National Institutes of Health Intramural Research Program, Center for Cancer Research, National Cancer Institute., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1

  • Azkona, Garikoitz
  • López de Maturana, Rakel
  • Rio, Patricia del
  • Sousa, Amaya
  • Vazquez, Nerea
  • Zubiarrain, Amaia
  • Jimenez-Blasco, Daniel
  • Bolaños, Juan P.
  • Morales, Blas
  • Auburger, Georg
  • Arbelo, José Matias
  • Sánchez-Pernaute, Rosario
Mutations in PINK1 (PARK6), a serine/threonine kinase involved in mitochondrial homeostasis, are associated with early onset Parkinson’s disease. Fibroblasts from Parkinson’s disease patients with compound heterozygous mutations in exon 7 (c.1488 + 1G > A; c.1252_1488del) showed no apparent signs of mitochondrial impairment. To elucidate changes primarily caused by lack of functional PINK1, we over-expressed wild-type PINK1, which induced a significant downregulation of LRRK2 (PARK8). Indeed, we found that LRRK2 protein basal levels were significantly higher in the mutant PINK1 fibroblasts. To examine the interaction between the two PARK genes in a disease-relevant cell context, we generated induced pluripotent stem cell (iPSC) lines from mutant, carrier and control fibroblasts by lentiviral-mediated re-programming. Efficiency of neural induction and dopamine differentiation using a floor-plate induction protocol was similar in all genotypes. As observed in fibroblasts, PINK1 mutant neurons showed increased LRRK2 expression both at the RNA and protein level and transient over-expression of wild-type PINK1 efficiently downregulated LRRK2 levels. Additionally, we confirmed a dysregulation of LRRK2 expression in fibroblasts from patients with a different homozygous mutation in PINK1 exon 4, c.926G > A (G309D). Thus, our results identify a novel role of PINK1 modulating the levels of LRRK2 in Parkinson’s disease fibroblasts and neurons, suggest a convergent pathway for these PARK genes, and broaden the role of LRRK2 in the pathogenesis of Parkinson’s disease., This study is funded by grants from the European Commission, CORDIS FP7, HEALTH-2, 278871 (DDPDGENES), and the Joint Program in Neurodegenerative Diseases (DAMNDPATHS) to RSP. JPB is the recipient of grants from MINECO (SAF2013-41177-R) and the NIH/NIDA (1R21DA037678-01). GAu is the recipient of grants from DFG (AU96/10-1) and the German National Genome Research Network NGFNplus (Neuron-Parkinson-subproject 7)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondrial Complex I Activity is Conditioned by Supercomplex I–III2–IV Assembly in Brain Cells: Relevance for Parkinson’s Disease

  • López-Fabuel, Irene
  • Resch-Beusher, Monica
  • Carabias-Carrasco, Mónica
  • Almeida, Angeles
  • Bolaños, Juan P.
The assembly of complex I (CI) with complexes III (CIII) and IV (CIV) of the mitochondrial respiratory chain (MRC) to configure I–III- or I–III–IV-containing supercomplexes (SCs) regulates mitochondrial energy efficiency and reactive oxygen species (mROS) production. However, whether the occurrence of SCs impacts on CI specific activity remains unknown to our knowledge. To investigate this issue, here we determined CI activity in primary neurons and astrocytes, cultured under identical antioxidants-free medium, from two mouse strains (C57Bl/6 and CBA) and Wistar rat, i.e. three rodent species with or without the ability to assemble CIV into SCs. We found that CI activity was 6- or 1.8-fold higher in astrocytes than in neurons, respectively, from rat or CBA mouse, which can form I–III2–IV SC; however, CI activity was similar in the cells from C57Bl/6 mouse, which does not form I–III2–IV SC. Interestingly, CII–III activity, which was comparable in neurons and astrocytes from mice, was about 50% lower in astrocytes when compared with neurons from rat, a difference that was abolished by antioxidants- or serum-containing media. CIV and citrate synthase activities were similar under all conditions studied. Interestingly, in rat astrocytes, CI abundance in I–III2–IV SC was negligible when compared with its abundance in I–III-containing SCs. Thus, CIV-containing SCs formation may determine CI specific activity in astrocytes, which is important to understand the mechanism for CI deficiency observed in Parkinson’s disease., J.P.B. is funded by MINECO (SAF2013-41177-R, SAF2016-78114-R), CIBER on Frailty and Aging from the Instituto de Salud Carlos III (CB16/10/00282), E.U. SP3-People-MC-ITN programme (608381), EU BATCure Grant (666918) and FEDER (European regional development fund). A.A.P. is funded by the Instituto de Salud Carlos III (RD12/0014/0007)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

El complejo MDM2-P53 es esencial en la tolerancia isquémica neuronal inducida por el precondicionamiento

  • Vecino, Rebeca
Tesis doctoral presentada para lograr el título de Doctor por la Universidad de Salamanca, Un estímulo subtóxico en el cerebro (PC) promueve una situación de resistencia transitoria, que lo protege frente a un daño isquémico agudo posterior. Este estado de tolerancia isquémica se debe a la activación de mecanismos endógenos que promueven la supervivencia neuronal (Dirnagl et al., 2009, 2003; Gidday, 2006; Kirino, 2002; Wang et al., 2015). De hecho, se ha observado que aquellos pacientes que sufren, previo al ictus, uno o varios AITs presentan un mejor pronóstico funcional que aquellos pacientes sin AIT (Schaller, 2005; Wang et al., 2017; Wegener et al., 2004). Por ello, en la actualidad, se considera al AIT como el correlato clínico de una situación de PC. Así, el PC constituye una herramienta experimental eficaz en la identificación de las vías de neuroprotección asociadas a la tolerancia neuronal y frente a la isquemia. El empleo de dos modelos de PC distintos (NMDA-PC e IPC) ha permitido identificar, tanto in vitro como in vivo, las vías de señalización p53/PUMA/Caspasa-3 y Akt/MDM2/p53 con un papel clave en el balance entre la supervivencia y la muerte neuronal tras la isquemia. Así, el PC induce la fosforilación temprana de Akt, cuya activación promueve la fosforilación de MDM2 y posterior translocación al núcleo celular. De este modo, se fomenta la formación del complejo MDM2-p53, clave para la desestabilización de la proteína p53. Todo esto previene la activación de la vía proapoptótica p53/PUMA/Caspasa-3 y favorece la supervivencia neuronal tras la isquemia (Vecino et al., 2018). Resultados previos de nuestro grupo han identificado que el polimorfismo humano o SNP Arg72Pro de Tp53 modula la susceptibilidad de las neuronas a la isquemia y condiciona el pronóstico funcional de pacientes de ictus isquémico y hemorrágico (Gomez-Sanchez et al., 2011). Además, este SNP determina la neovascularización y recuperación neurológica tras el ictus hemorrágico (Rodríguez et al., 2017). En este sentido, hemos identificado la función moduladora del polimorfismo Arg72Pro de Tp53 en la supervivencia neuronal asociada al PC y su relevancia clínica en el pronóstico funcional de pacientes que experimentan un AIT previo al ictus (Ramos-Araque et al., 2019)., Este trabajo ha sido financiado con subvenciones concedidas por el Ministerio de Ciencia, Innovación y Universidades, a través de una ayuda para la formación de profesorado universitario (FPU; BOE A-2015-12849); así como una ayuda para financiar la contratación predoctoral de personal investigador de la Junta de Castilla y León (ORDEN EDU/128/2015). Asimismo, este trabajo se ha financiado mediante los proyectos del Ministerio de Economía, Industria y Competitividad (SAF 2013-41177-R, SAF 2016-78114-R); el Instituto de Salud Carlos III (CP0014/00010, PI12/00685, PI15/00473, RD16/0019/0018); la Junta de Castilla y León (BIO/SA35/15) y los fondos FEDER (European regional development funding).